Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 13,100 AKTX shares, $103.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 13,100 | $103.5K |
| Jun 18, 2026 | ARDELYX, INC. (ARDX) | Grant/Award | 26,455 | n/a |
| May 27, 2026 | Nuvation Bio Inc. (NUVB) | Grant/Award | 123,397 | n/a |
| Dec 19, 2025 | Akari Therapeutics Plc (AKTX) | Purchase | 123,731 | n/a |
| Jun 24, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 41,551 | n/a |
| May 23, 2025 | Nuvation Bio Inc. (NUVB) | Grant/Award | 292,983 | n/a |
| Mar 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 175,000 | n/a |
| Mar 10, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 44,642 | $50.0K |
| Sep 18, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 5,000,000 | n/a |
| Sep 5, 2024 | Nuvation Bio Inc. (NUVB) | Grant/Award | 200,801 | n/a |